Infliximab monotherapy for neuro-Behçet's disease: a case report

J Neurol Sci. 2014 Dec 15;347(1-2):389-90. doi: 10.1016/j.jns.2014.09.052. Epub 2014 Oct 7.

Authors

Massimiliano Di Filippo¹, Maria Di Gregorio², Carlotta Nannini³, Lorenzo Gaetani², Cristina Gallina⁴, Piero Floridi⁴, Paola Sarchielli², Paolo Calabresi⁵, Fabrizio Cantini³

Affiliations

¹ Clinica Neurologica, Università degli Studi di Perugia, Perugia, Italy. Electronic address: massimiliano.difilippo@unipg.it.
² Clinica Neurologica, Università degli Studi di Perugia, Perugia, Italy.
³ U.O.C. di Reumatologia, Ospedale di Prato, Prato, Italy.
⁴ S.C. Neuroradiologia, Azienda Ospedaliera di Perugia, Perugia, Italy.
⁵ Clinica Neurologica, Università degli Studi di Perugia, Perugia, Italy; IRCCS Fondazione S Lucia, Roma, Italy.

PMID: 25456463
DOI: 10.1016/j.jns.2014.09.052

No abstract available

Keywords: Infliximab; Neuro-Behçet.

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / therapeutic use*
Behcet Syndrome / drug therapy*
Behcet Syndrome / pathology
Brain / pathology*
Female
Humans
Infliximab
Magnetic Resonance Imaging*
Treatment Outcome

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal
Infliximab